Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Fecci Appointed Associate Deputy Director, Brain Tumor Center

Peter E. Fecci , MD, PhD, has been appointed associate deputy director of the Preston Robert Tisch Brain Tumor Center. “Dr. Fecci has had a highly decorated research career,” wrote David Ashley, MBBS (Hon), FRACP, PhD, Director of The Preston Robert Tisch Brain Tumor Center, in a recent...

Survivor Commits To Changing The Course Of Cancer

According to the American Cancer Society, one in two men and one in three women in the United States will be affected by cancer in their lifetime. It is estimated that in 2018 there will be 1,735,350 new cancer cases diagnosed — 55,130 of those in North Carolina. In keeping with its mission to...

Seed Funds Awarded For Financial Toxicity Study

Duke Cancer Institute radiation oncologists Yvonne Mowery, MD, PhD; David Brizel, MD; and Fumiko Chino, MD; have been granted $50,971 in seed funding by the Radiation Oncology Institute (ROI) (affiliated with the American Society for Radiation Oncology) for their forthcoming study evaluating...

For Virginia Man, The New Year Was Nothing To Toast

As a new year ushers in, so does a time of renewed hope and new beginnings. Instead of ringing in the new year as is customary, Curtis Garbett found himself during the waning hours of 2015 learning he had cancer. “I couldn’t believe what I was hearing,” said Garbett. “I was only 39 years old; my...

Angels Among Us Raises Record $2.3 Million

More than 4,000 participants attended the 25th Annual Angels Among Us 5K on Saturday, April 28. Together, they raised a record $2.3 million to support the brain tumor research at Duke. "We are very grateful for the support we experienced this year," said Ellen Stainback, director of external...

Two-Time Cancer Survivor, Jazz Artist, Gives DCI Benefit Concert

The Calvin Edwards Trio invites the public to “A Night of Jazz to Benefit Cancer Research at Duke” on Friday, May 18, at 8 p.m. at Duke University’s Nelson Music Room. International jazz and blues guitarist, vocalist, and songwriter Calvin Edwards organized the concert — with bandmates Doug...

Boswell Named Manager Of Oncology Patient Education

Amy Boswell, MSN, RN, OCN, has been named to serve as manager of the Oncology Patient Education Program. "As manager, Amy will provide administrative direction for oncology patient education, including managing and coordinating the development, implementation, and evaluation of patient education...

Find A Supportive Care And Survivorship Day Close To Home

This year Duke Cancer Institute will host its annual Supportive Care and Survivorship Day on two days and at two locations — Tuesday, June 5, at Duke Cancer Center Raleigh and Wednesday, June 6, at Duke Cancer Center Durham. “Our Supportive Care and Survivorship Day is a day set aside for...

Salama Named Director Of Melanoma Program

April Salama, MD, previously interim director of Duke Cancer Institute’s Melanoma Program, was recently named director of the program. Since assuming the role as interim director three years ago, Salama has advanced the melanoma program at Duke Cancer Institute. "Dr. Salama continues to expand the...

Research Award Established In Honor Of DCI Executive Director

In 2002 the American Association for Cancer Research (AACR) launched Molecular Cancer Research ( MCR ) appointing Michael B. Kastan, MD, PhD, to the helm as the publication’s founding editor-in-chief. Kastan, executive director of Duke Cancer Institute, is recognized as having attracted scientific...

Aptamers May Form New, Safer Chemotherapy Delivery Systems

Using chemotherapy along with aptamers—lab-made molecules that function like antibodies—Duke Health researchers showed that they can zero in on and kill prostate cancer tumors in mice while leaving healthy tissue unscathed. The finding suggests that aptamers could form the basis of new cancer...

IRONMAN Trial Enrolling Prostate Cancer Patients

The International Registry for Men with Advanced Prostate (IRONMAN), the first international clinical trial registry for prostate cancer, is open for enrollment. The registry aims to enroll 5,000 patients over the next three years at several institutions worldwide, including 2,500 from the United...

Pages